Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Methylation patterns define two types of hyperplastic polyp associated with colorectal cancer.

Wynter CV, Walsh MD, Higuchi T, Leggett BA, Young J, Jass JR.

Gut. 2004 Apr;53(4):573-80.

2.

BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer.

Deng G, Bell I, Crawley S, Gum J, Terdiman JP, Allen BA, Truta B, Sleisenger MH, Kim YS.

Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):191-5.

3.

Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas.

Koinuma K, Shitoh K, Miyakura Y, Furukawa T, Yamashita Y, Ota J, Ohki R, Choi YL, Wada T, Konishi F, Nagai H, Mano H.

Int J Cancer. 2004 Jan 10;108(2):237-42.

4.

BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair.

Wang L, Cunningham JM, Winters JL, Guenther JC, French AJ, Boardman LA, Burgart LJ, McDonnell SK, Schaid DJ, Thibodeau SN.

Cancer Res. 2003 Sep 1;63(17):5209-12.

5.

BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas.

Chan TL, Zhao W, Leung SY, Yuen ST; Cancer Genome Project..

Cancer Res. 2003 Aug 15;63(16):4878-81.

6.

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd LE, Tu D, Redston M, Gallinger S.

N Engl J Med. 2003 Jul 17;349(3):247-57.

7.

Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas.

Goldstein NS, Bhanot P, Odish E, Hunter S.

Am J Clin Pathol. 2003 Jun;119(6):778-96.

PMID:
12817424
8.

Hyperplastic-like polyps as precursors of microsatellite-unstable colorectal cancer.

Jass JR.

Am J Clin Pathol. 2003 Jun;119(6):773-5. No abstract available.

PMID:
12817423
9.

Raf proteins and cancer: B-Raf is identified as a mutational target.

Mercer KE, Pritchard CA.

Biochim Biophys Acta. 2003 Jun 5;1653(1):25-40. Review.

PMID:
12781369
10.

BRAF mutation in papillary thyroid carcinoma.

Cohen Y, Xing M, Mambo E, Guo Z, Wu G, Trink B, Beller U, Westra WH, Ladenson PW, Sidransky D.

J Natl Cancer Inst. 2003 Apr 16;95(8):625-7.

PMID:
12697856
11.

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma.

Singer G, Oldt R 3rd, Cohen Y, Wang BG, Sidransky D, Kurman RJ, Shih IeM.

J Natl Cancer Inst. 2003 Mar 19;95(6):484-6.

PMID:
12644542
12.

Frequent CpG island methylation in serrated adenomas of the colorectum.

Park SJ, Rashid A, Lee JH, Kim SG, Hamilton SR, Wu TT.

Am J Pathol. 2003 Mar;162(3):815-22.

13.

The serrated neoplasia pathway.

Hawkins NJ, Bariol C, Ward RL.

Pathology. 2002 Dec;34(6):548-55. Review.

PMID:
12555993
14.

Mutation searching in colorectal cancer studies: experience with a denaturing high-pressure liquid chromatography system for exon-by-exon scanning of tumour suppressor genes.

Young J, Barker M, Fraser L, Walsh MD, Spring K, Biden KG, Hopper JL, Leggett BA, Jass JR.

Pathology. 2002 Dec;34(6):529-33.

PMID:
12555990
15.

Morphologic reappraisal of serrated colorectal polyps.

Torlakovic E, Skovlund E, Snover DC, Torlakovic G, Nesland JM.

Am J Surg Pathol. 2003 Jan;27(1):65-81.

PMID:
12502929
16.

High frequency of BRAF mutations in nevi.

Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM, Meltzer PS.

Nat Genet. 2003 Jan;33(1):19-20. Epub 2002 Nov 25.

PMID:
12447372
17.

Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.

Yuen ST, Davies H, Chan TL, Ho JW, Bignell GR, Cox C, Stephens P, Edkins S, Tsui WW, Chan AS, Futreal PA, Stratton MR, Wooster R, Leung SY.

Cancer Res. 2002 Nov 15;62(22):6451-5.

18.

Morphological and molecular heterogeneity within nonmicrosatellite instability-high colorectal cancer.

Whitehall VL, Wynter CV, Walsh MD, Simms LA, Purdie D, Pandeya N, Young J, Meltzer SJ, Leggett BA, Jass JR.

Cancer Res. 2002 Nov 1;62(21):6011-4. Erratum in: Cancer Res 2002 Dec 1;62(23):7132.

19.

Use of denaturing HPLC to provide efficient detection of mutations causing familial hypercholesterolemia.

Bodamer OA, Bercovich D, Schlabach M, Ballantyne C, Zoch D, Beaudet AL.

Clin Chem. 2002 Nov;48(11):1913-8.

20.

Emerging concepts in colorectal neoplasia.

Jass JR, Whitehall VL, Young J, Leggett BA.

Gastroenterology. 2002 Sep;123(3):862-76. Review.

PMID:
12198712

Supplemental Content

Support Center